The Praemium Ltd (ASX: PPS) share price is up 4%, the financial technology business revealed its December 2018 quarterly figures.
Praemium was established in Australia in 2001. It’s a provider of investment platforms, investment management, portfolio administration and CRM solutions with offices in Australia, the UK, Jersey, Armenia and Hong Kong. Praemium launched its services into the UK market in 2008, where it is now one of the fastest growing discretionary platforms available.
Praemium’s record December 2018 quarter
In the December 2018 quarter, Praemium achieved combined quarterly gross inflows of $768 million, the highest on record. Australian gross inflows came in at $585 million and international gross inflows of $183 million.
During 2018 Praemium had record annual gross inflows of $2.8 billion, which was 10% higher than the 2017 calendar year. The company is benefiting from advisers looking to find cheaper independent platforms after the big institutions like National Australia Bank Ltd (ASX: NAB) and AMP Limited (ASX: AMP) suffered reputation damage in the Royal Commission.
The company reported a few bits of news regarding its UK growth. UK platform clients increased by 34% from 136 to 182. Praemium achieved record UK gross platform inflows of £97 million for the December quarter.
Praemium CEO Michael Ohanessian commented on what to expect in 2019, “In the new year we will reach a key milestone with the imminent release of our signature development program – a next generation Unified Managed Accounts (UMA) solution”.
Whilst this update was good, Praemium is not the type of business I want to add to my own portfolio as it’s not easy for me to think at what price it would be good value.
Praemium isn’t the only business that is growing strongly each year. The two ASX shares mentioned in the free report below are growing globally.
After searching through a market with over 2,000 shares, our lead expert investment analyst has narrowed it down to just 2 of his favourite rapid-growth shares in a FREE report to Rask Media readers.
Over the past five years, these two shares have gone from being 'tiny caps' to being serious contenders for the ASX 200.
Idea #1 is taking on the world, starting with the huge USA market. In a just a few short years the company has snatched market share away from rivals and is on its way to being the market leader.
Idea #2 uses a 'printer and cartridge' type model to get large and established customers: a) using their healthcare industry-leading product, b) paying for it again and again and again... so it's little wonder this company is tipped to grow at a rapid pace in 2019.
Access the free report by clicking here now. Absolutely no credit card or payment details required.
Disclaimer: Any information contained in this article is limited to general financial/investment advice only. The information has not taken into account your specific needs, goals or objectives, so please consider consulting a licenced and trusted adviser before acting on the information. Please read The Rask Group’s Financial Services Guide (FSG) for more information. This article is authorised by Owen Raszkiewicz of The Rask Group, which is a corporate authorised representative No. 1264179 of Strawman Pty Ltd (ACN: 610 908 211) (AFSL: 501 223).